
20 Jul Umoja Biopharma
David Fontana, Ph.D., Chief Operating Officer and Chief Business Officer
Oct. 8 | 1:15pm | FLW Ballroom G
Seattle, WA
(Private)
Umoja is an in vivo gene delivery immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of CAR T cell therapies in oncology and autoimmunity.